UMECLIDINIUM/VILANTEROL

What is umeclidinium/vilanterol (Anoro Ellipta)?

Umeclidinium/vilanterol is part of a class of medications used to treat the inflammatory respiratory condition of chronic obstructive pulmonary disease (COPD). It contains an anticholinergic, umeclidinium, and a bronchodilator, vilanterol. Both medications are used to help open and relax the airways, making it easier to breathe.

How can umeclidinium/vilanterol be used to treat long-COVID?

Patients with long-COVID have symptoms such as chronic fatigue, pulmonary problems, and exercise intolerance. Due to umeclidinium/vilanterol’s mechanism of action in opening the airways, those suffering with breathing issues from long-COVID may be positively impacted. Although no formal studies have been conducted to determine how effective this treatment is, patients have reported positive results [1]. Umeclidinium/vilanterol is not indicated for the treatment for long-COVID but could provide symptom management by increasing lung capacity, exercise intolerance, and decreasing inflammation in the lungs.

References:

¹ https://healthunlocked.com/asthmalunguk-lung/posts/147776793/anoro-ellipta-have-you-had-side-effects /